Pediatric Hydrops Fetalis Workup

  • Author: Ashraf H Hamdan, MD, MBBCh, MSc, MRCP; Chief Editor: Ted Rosenkrantz, MD   more...
 
Updated: May 2, 2012
 

Laboratory Studies

  • Diagnostic studies may be considered best by temporal grouping (ie, fetal, maternal, placental, neonatal, postmortem). Assessments generally proceed from low-risk noninvasive tests to higher-risk invasive techniques as required for precise and complete diagnosis to properly manage the individual pregnancy.
  • Obtain several maternal laboratory studies concurrent with the initial fetal imaging assessment.
    • Assessment of maternal blood type (red cells) and antibody screen (identification, and quantitation when indicated, of maternal plasma antibodies) are standard screening tests recommended in most guidelines for prenatal care. Recently, the introduction of new molecular genetic techniques (eg, PCR) has demonstrated considerable promise; however, definitive comparisons with standard methods are not yet available. More than 85% of Rh-sensitized women whose anti-D titers were 1:512 or higher were found to be HLA type DQBI allele*0201. Although this single study suggests that HLA typing may be of value in the prospective management of isoimmunization, this observation requires confirmation and further study.
    • Qualitative and quantitative estimates of the proportion of red cells containing fetal hemoglobin in the maternal circulation are of particular value.
      • The Betke-Kleihauer technique depends on the different vulnerability of cells containing fetal hemoglobin from those with adult hemoglobin when subjected to acid-elution.
      • A newer method using flow cytometry has also been found to be useful.
      • Results using either method must be interpreted with considerable caution, since poor sensitivity and specificity of these diagnostic tests has been demonstrated in several studies.
    • The search for maternal-fetal infection must be intensive. Syphilis serology was a standard prenatal screening test for decades. More recently, the test has been used more selectively, despite the absence of any good evidence for this change. If fetal hydrops is suspected, syphilis serology is mandatory with repeat serial testing and, very importantly, with dilution of maternal serum. The prozone effect has been demonstrated repeatedly with fetal hydrops due to syphilis, thus dilution of maternal serum to avoid false-negative results is required.
    • Antibody screens for common fetal infections (toxoplasmosis, other infections, rubella, CMV infection, and herpes simplex [TORCH]) and more sensitive and specific enzyme-linked immunosorbent assay (ELISA) studies for individual infectious agents have been used for many years. More recently, the PCR technique is generally accepted as the criterion standard and should be used whenever possible.
    • Hemoglobin electrophoresis for alpha-thalassemia heterozygosity has been useful in ethnically at-risk populations. In regions where ethnic diversity is high, routine screening may be preferable to selection based on ethnicity. More recently, PCR screens and colorimetric monoclonal antizeta antibody tests for heterozygote alpha-thalassemia have been demonstrated as economically feasible screening procedures.
    • Maternal serum screening tests (multiple-marker, triple-screen, triple-marker), commonly used if fetal anomaly is suspected, are of uncertain value with fetal hydrops.
      • In one study, positive screening tests (any of the 3 used) with a sensitivity of only 60% in 19 cases of Turner syndrome distinguished some fetuses with cystic hygroma and/or hydrops from those without. Individual components of these tests were examined separately in several other studies.
      • Elevated AFP levels have been reported in hydrops associated with fetomaternal hemorrhage, umbilical cord hemangioma, polycystic kidneys, CMV, and parvovirus; however, AFP levels are similar in babies with Turner syndrome with or without hydrops. Use of AFP screening as an index of fetal aplastic crisis in maternal Parvovirus infection has been recommended but is of dubious value because several fetal deaths have been observed with AFP levels within reference range. The precise diagnostic value of AFP screening is uncertain because definitive studies are not available.
      • Low levels of unconjugated estriol (uE3) have been found in one hydropic baby with Smith-Lemli-Opitz syndrome, but the test has not demonstrated value in distinguishing between babies with or without hydrops, and normal levels have been observed in several hydropic deaths.
      • Human chorionic gonadotropin levels have been reported as significantly elevated in hydrops with sacrococcygeal teratoma, choriocarcinoma, Parvovirus, Turner syndrome, and Down syndrome; however, these levels have also been normal in several hydropic fetal deaths related to Parvovirus.
      • In a single study, inhibin-A levels were markedly elevated in 12 fetuses with Turner syndrome with hydrops and were reduced significantly in those fetuses without hydrops.
      • Maternal serum IgG placental alkaline phosphatase levels are increased with fetal hydrops; currently, clinical utility of this finding is untested.
  • Direct invasive sampling studies of fetal AF (amniotic fluid) or placental tissues or fluids have demonstrated value for definitive diagnosis, monitoring of treatment efficacy, and accurate prognosis in a number of conditions associated with hydrops.
    • Elevated levels of AF bilirubin, as measured by the spectrophotometric extrapolation technique first described by Liley, have been demonstrated to be highly sensitive predictors of the severity of fetal anemia due to isoimmunization.[19]
      • Specificity is somewhat less because alpha-feto bilirubin may also be elevated due to maternal hemoglobinopathy or hepatitis and in association with impaired fetal swallowing due to fetal gastrointestinal obstruction and a number of fetal CNS disorders.
      • Recent reports have suggested the use of ultrasonographic methods to detect fetal anemia; however, routine use of such noninvasive methods is not justified in the absence of definitive evidence of their superior sensitivity and specificity, at less risk, when compared with the standard proven method of AF bilirubin analysis.
    • Direct enzyme assays or biochemical analyses of measurements of levels of specific metabolic products may be indicated in the pregnancy at risk of hydrops because of inborn errors of metabolism.
      • Such studies may use samples from the mother and father (red cells, serum, urine, tissue), fetus (skin fibroblast cultures or leukocytes from AF, fetal red cells, white cells, serum samples from direct cordocentesis, serous effusions), placenta (chorionic villous sampling, placental biopsy), or AF.
      • Examples include biochemical analyses of urine or AF for abnormal oligosaccharide, mucopolysaccharide, and sphingolipid metabolites when lysosomal disorders are suspected or determination of AF 7-dehydrocholesterol reductase if history and findings suggest Smith-Lemli-Opitz syndrome.
    • Fetal serum endothelin levels are elevated more than 2-fold in recipients; however, these levels are normal in donors with twin-to-twin transfusion syndrome. Endothelin levels were related to presence of and severity of hydrops in these cases. Changes in fetal serum liver enzymes, particularly alanine transaminase and glutamyl transpeptidase, have been demonstrated to occur following correction of the anemia by fetal transfusion. Whether or not these observations may be of diagnostic or prognostic use is currently untested.
    • Direct fetal diagnostic studies for Parvovirus include histologic staining methods (RBC), digoxigenin-labeled B19. DNA probe (PCR), and avidin-biotin complex immunohistochemical and immunofluorescent studies, among others. Currently, PCR methods appear to be best, although definitive studies providing sensitivity and specificity are not available.
    • Karyotyping is always indicated if history or ultrasound results reveal a constellation of findings consistent with a chromosomal aberration or if maternal or family history is suggestive.
      • Chromosome studies are indicated whenever initial diagnostic studies have failed to identify with certainty a specific cause for the fetal hydrops.
      • Chromosomal analyses may be performed on desquamated fetal epithelial cells in AF, fetal tissue biopsy samples, or placental (fetal tissue) biopsy samples.
      • An increase in AFP has been observed in almost 1 in 10 (8.4%) genetic amniocenteses; fetal mortality exceeded 1 in 10 (14%) when such AFP elevations occurred. Evidence of fetomaternal bleeding is present in 3 of 4 chorionic villous samplings. Thus, careful weighing of benefit versus risk must be made whenever direct invasive diagnostic methods are considered.
    • To obtain more precise information concerning fetal status, direct fetal sampling by cordocentesis (or periumbilical sampling) has been used with increasing frequency.
      • Acidemia, hypoxemia, and hypercarbia are found in most studies of fetal acid-base balance and blood-gas status obtained at time of direct fetal treatment. These results are nonspecific and anticipated, and, although they may be of use in immediate management, they are unlikely to be of value in longer-term care of the fetus with hydrops.
      • Analyses of serous effusion fluids (pleural, pericardial, or ascitic, most commonly) have been of surprisingly little value. For example, lymphocyte counts considered characteristic of congenital chylothorax when found in the newborn infant have been observed in pleural effusions from fetuses with CMV disease.
      • Serologic tests for specific infections, hemoglobin or hematocrit measurements, platelet counts, white cell counts and morphologic analyses, specific enzyme analyses, and karyotyping are just a few of the more common measurements obtained. While this information may be invaluable in specific cases, use of such invasive methods on a routine basis carries significant risks.
      • Fetal sampling by cordocentesis is followed by significant bradycardia in almost 1 in 20 samplings (3.8%); of those with such complications, almost two thirds die (61.5%).
    • Elevated AF alkaline phosphatase has been observed in association with fetal hydrops due to Turner syndrome; although likely to be a nonspecific finding, further study is necessary.
  • The fetal biophysic profile has been demonstrated to be abnormal in severe fetal hydrops.
    • Cardiotocographic records obtained 12 hours prior to fetal death demonstrate absence of short-term and long-term variability, absence of tachycardia, presence of late decelerations, and terminal bradycardia.
    • Sinusoidal heart-rate patterns have been observed consistently in hydrops associated with severe fetal anemia related to isoimmunization and fetomaternal hemorrhage.
Next

Imaging Studies

  • Once the possibility of fetal hydrops is considered or suspected, sophisticated and complete fetal imaging studies are an initial absolute necessity. Hydrops is defined by the presence of serous effusions in a fetus with subcutaneous tissue edema. Some authors have distinguished the presence of a single effusion (pleural, peritoneal) as an entity distinct from hydrops; however, recent evidence suggests that an isolated effusion often (if not usually) progresses to overt fetal hydrops. Exceptions appear to be isolated chyloperitoneum/ascites (usually associated with obstructive uropathy and, thus, not true hydrops) and pleural or peritoneal effusions that regress spontaneously (see Treatment). Thus, careful, complete and serial imaging is required to establish the diagnosis and the extent of the hydrops.
  • Examples of radiographic findings are shown in the images below.Chest radiograph revealing pleural effusion with bChest radiograph revealing pleural effusion with bilateral chest tubes and severe edema. Chest and abdomen radiograph revealing severe edemChest and abdomen radiograph revealing severe edema and ascites. Chest and abdomen radiograph revealing severe edemChest and abdomen radiograph revealing severe edema, pleural effusion, and bilateral chest tubes. Umbilical artery catheter, umbilical vein catheter, and endotracheal tube in place.
  • The equipment used must be capable of providing high-resolution images at large depth.
    • Linear array transducers are commonly used; however, sector scanners provide better views of the heart and many other structures.
    • Range-gated Doppler capability is optimal for functional physiologic assessments. Use of high-frequency transvaginal 2-dimensional and pulsed-wave/color Doppler flow mapping particularly has been promising.
  • The initial imaging study may provide important clues concerning the origin of the fetal condition. For example, most arrhythmias and anomalies may be detected even in the process of establishing the initial diagnosis. However, in most cases, more complex, serially repeated studies may be required to accurately define the constellation of findings in the fetus.
  • Specific echocardiographic assessment of fetal cardiac structure and function is required in most cases of fetal hydrops. Essential elements of this examination should include definitive results concerning (1) assessment of biventricular outer dimensions in diastole and of the cardiothoracic ratio, (2) presence or absence of AV valve regurgitation, and (3) umbilical vessel blood flow velocities and pulsations.
    • Biventricular diameter in diastole had 100% sensitivity and 86% specificity for detection of cardiac failure in one study. These observations, confirmed by results from several other reports, address the basic underlying pathophysiologic disturbance in faltering cardiac output of the fetus with hydrops and increased CVP.
    • Presence of AV valve regurgitation is a common finding, suggesting right-heart failure or increased preload. Persistence of serious functional AV valve incompetence following treatment interventions is ominous, particularly in terms of fetal outcome. The proportion of atrial area taken up by the regurgitant jet is related to hydrops. The proportion of systolic time during which AV valve insufficiency is demonstrated is also related to hydrops. In one study, AV valve insufficiency was pansystolic in all babies with hydrops.
    • Umbilical and fetal abdominal vessel pulsations, flow velocities, and waveforms have been studied by several investigators in hydrops caused by tachyarrhythmias, alpha-thalassemia, and twin-twin transfusion.
      • Because sensitivity, specificity, and predictive values are not available, the practical clinical value of these studies is uncertain.
      • However, the results available to date suggest that they may provide valuable quantitative and qualitative pathophysiologic information and may even be predictive of fetal deterioration prior to the development of overt hydrops in some situations.
    • Umbilical venous (UV) blood flow, normally nonpulsatile, demonstrates pulsatile (or double-pulsatile) flow, a finding consistent with an increased fetal CVP.
      • Pulsed Doppler duplex ultrasound studies demonstrate higher UV and inferior vena cava (IVC) blood velocity and blood flow, suggesting an increase in the preload (cardiac) index. Studies of IVC, hepatic vein, and ductus venosus blood flow demonstrate similar results.
      • In hydrops caused by sustained tachycardia, reversal of blood flow (or increased retrograde flow) with systolic forward flow and diastolic reverse flow is present at heart rates exceeding 220 bpm; these abnormalities are reversed by successful fetal treatment with return of the heart rate to 210 bpm or less. Great interindividual differences in the time required for this reversal are observed.
    • Myocardial function is impaired with hydrops, and the severity of this functional cardiomyopathy is reflected by the degree and persistence of AV valve incompetence and UVC/IVC flow patterns in the fetus.
    • Abnormalities in umbilical artery (UA) blood flow are also found. UA early-diastolic blood flow velocity is absent, and end-diastolic UA velocity is reversed. The UA pulsatility index (PI) is increased in feto-fetal transfusion hydrops, and, most importantly, this abnormal finding usually precedes and predicts the development of hydrops in the recipient/hydropic twin. PI also improves parallel to clinical improvement in fetal condition. Abnormal UA blood flow patterns in alpha-thalassemia hydrops include an increased acceleration slope, more linear decline from maximum systole to end diastole, and reduced spectral broadening; fetal aortic waveforms also demonstrate distorted systolic peaks, flow turbulence, and greatly elevated diastolic frequencies.
    • Elevated umbilical venous pressures, found in approximately two thirds of individuals with fetal hydrops, return to normal with successful treatment. Such measurements, obtained by cordocentesis at time of fetal treatment, may be useful in assessing the success of fetal therapies that require a direct invasive approach.
Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Ashraf H Hamdan, MD, MBBCh, MSc, MRCP  Clinical Associate Professor of Pediatrics, Vanderbilt University Medical Center; Neonatologist, Pediatrix Medical Group of Nashville

Ashraf H Hamdan, MD, MBBCh, MSc, MRCP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

David N Sheftel  MD, Assistant Professor of Pediatrics, Chicago Medical School at Rosalind Franklin University of Medicine and Science

David N Sheftel is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine and American Academy of Pediatrics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Arun K Pramanik, MD, MBBS  Professor of Pediatrics, Director of Neonatal Fellowship, Louisiana State University Health Sciences Center

Arun K Pramanik, MD, MBBS is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, National Perinatal Association, and Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Carol L Wagner, MD  Professor of Pediatrics, Medical University of South Carolina

Carol L Wagner, MD is a member of the following medical societies: American Academy of Pediatrics, American Chemical Society, American Medical Women's Association, American Public Health Association, American Society for Bone and Mineral Research, American Society for Clinical Nutrition, Massachusetts Medical Society, National Perinatal Association, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD  Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine

Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Pediatric Society, Connecticut State Medical Society, Eastern Society for Pediatric Research, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author, George Cassady, MD, to the development and writing of this article.

References

  1. Bellini C, Hennekam RC. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A. Mar 2012;158A(3):597-605. [Medline].

  2. Pasman SA, Meerman RH, Vandenbussche FP, Oepkes D. Hypoalbuminemia: a cause of fetal hydrops?. Am J Obstet Gynecol. Apr 2006;194(4):972-5. [Medline].

  3. Blair DK, Vander Straten MC, Gest AL. Hydrops in fetal sheep from rapid induction of anemia. Pediatr Res. May 1994;35(5):560-4. [Medline].

  4. Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. Mar 15 1997;29(4):709-15. [Medline].

  5. Kitsirisakul B, Steger HF, Sanguansermsri T. Frequency of alpha-thalassemia-1 of the Southeast Asian-type among pregnant women in northern Thailand determined by PCR technique. Southeast Asian J Trop Med Public Health. Jun 1996;27(2):362-3. [Medline].

  6. Abrams ME, Meredith KS, Kinnard P, Clark RH. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics. Jul 2007;120(1):84-9. [Medline].

  7. Lin SM, Wang CH, Zhu XY, Li SL, Lin SM, Fang Q. [Clinical study on 156 cases with hydrops fetalis]. Zhonghua Fu Chan Ke Za Zhi. Dec 2011;46(12):905-10. [Medline].

  8. Bellini C, Hennekam RC, Fulcheri E, Rutigliani M, Morcaldi G, Boccardo F. Etiology of nonimmune hydrops fetalis: A systematic review. Am J Med Genet A. Mar 30 2009;[Medline].

  9. Bowman J, Harman C, Manning F, et al. Intravenous drug abuse causes Rh immunization. Vox Sang. 1991;61(2):96-8. [Medline].

  10. Nakayama R, Yamada D, Steinmiller V, Hsia E, Hale RW. Hydrops fetalis secondary to Bart hemoglobinopathy. Obstet Gynecol. Feb 1986;67(2):176-80. [Medline].

  11. Joshi DD, Nickerson HJ, McManus MJ. Hydrops fetalis caused by homozygous alpha-thalassemia and Rh antigen alloimmunization: report of a survivor and literature review. Clin Med Res. Nov 2004;2(4):228-32. [Medline].

  12. Bachmaier N, Fusch C, Stenger RD, et al. Nonimmune hydrops fetalis due to enterovirus infection. Eur J Obstet Gynecol Reprod Biol. Jan 2009;142(1):83-4. [Medline].

  13. Meritet JF, Krivine A, Lewin F, Poissonnier MH, Poizat R, Loget P. A case of congenital lymphocytic choriomeningitis virus (LCMV) infection revealed by hydrops fetalis. Prenat Diagn. Feb 27 2009;[Medline].

  14. Essary LR, Vnencak-Jones CL, Manning SS, et al. Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods. Hum Pathol. Jul 1998;29(7):696-701. [Medline].

  15. Kiyota A, Tsukimori K, Yumoto Y, et al. Spontaneous resolution of cystic hygroma and hydrops in a fetus with Noonan's syndrome. Fetal Diagn Ther. 2008;24(4):499-502. [Medline].

  16. Iskender C, Tarim E, Yalcinkaya C. Prenatal diagnosis of right diaphragmatic eventration associated with fetal hydrops. J Obstet Gynaecol Res. May 2012;38(5):858-62. [Medline].

  17. Lee FL, Said N, Grikscheit TC, Shin CE, Llanes A, Chmait RH. Treatment of Congenital Pulmonary Airway Malformation Induced Hydrops Fetalis via Percutaneous Sclerotherapy. Fetal Diagn Ther. Feb 18 2012;[Medline].

  18. Stocker JT, Madewell JE, Drake RM. Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum Pathol. Mar 1977;8(2):155-71. [Medline].

  19. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by Rhesus sensitization. Am J Obstet Gynecol. 1961;82(6):1359-1370.

  20. [Guideline] Leduc L, Farine D, Armson BA, et al. Stillbirth and bereavement: guidelines for stillbirth investigation. J Obstet Gynaecol Can. Jun 2006;28(6):540-52. [Medline].

  21. Huang HR, Tsay PK, Chiang MC, Lien R, Chou YH. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol. Jan 2007;24(1):33-8. [Medline].

  22. Matsubara S, Ohmaru T, Ohkuchi A, Arai F, Kuwata T, Usui R. Mirror syndrome associated with hydropic acardius in triplet pregnancy. Fetal Diagn Ther. 2008;24(4):429-33. [Medline].

  23. Adzick NS, Harrison MR, Crombleholme TM, et al. Fetal lung lesions: management and outcome. Am J Obstet Gynecol. Oct 1998;179(4):884-9. [Medline].

  24. Anand A, Gray ES, Brown T, et al. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med. Jan 22 1987;316(4):183-6. [Medline].

  25. Andres RL, Brace RA. The development of hydrops fetalis in the ovine fetus after lymphatic ligation or lymphatic excision. Am J Obstet Gynecol. May 1990;162(5):1331-4. [Medline].

  26. Aubard Y, Derouineau I, Aubard V, et al. Primary fetal hydrothorax: A literature review and proposed antenatal clinical strategy. Fetal Diagn Ther. Nov-Dec 1998;13(6):325-33. [Medline].

  27. Azancot-Benisty A, Areias JC, Oberhansli I, et al. European Study on Maternal and Fetal Management of Fetal Supraventricular Tachyarrhythmia: Proposed Protocol for an International Project. J Matern Fetal Investig. Jun 1998;8(2):92-7. [Medline].

  28. Bajoria R, Sullivan M, Fisk NM. Endothelin concentrations in monochorionic twins with severe twin-twin transfusion syndrome. Hum Reprod. Jun 1999;14(6):1614-8. [Medline]. [Full Text].

  29. Barron SD, Pass RF. Infectious causes of hydrops fetalis. Semin Perinatol. Dec 1995;19(6):493-501. [Medline].

  30. Bejar R, Vigliocco G, Gramajo H, et al. Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol. May 1990;162(5):1230-6. [Medline].

  31. Blickstein I. The twin-twin transfusion syndrome. Obstet Gynecol. Oct 1990;76(4):714-22. [Medline].

  32. Bond SJ, Harrison MR, Schmidt KG, et al. Death due to high-output cardiac failure in fetal sacrococcygeal teratoma. J Pediatr Surg. Dec 1990;25(12):1287-91. [Medline].

  33. Brace RA. Effects of outflow pressure on fetal lymph flow. Am J Obstet Gynecol. Feb 1989;160(2):494-7. [Medline].

  34. Brans YW, Milstead RR, Bailey PE, Cassady G. Blood-volume estimates in Coombs-test-positive infants. N Engl J Med. Jun 27 1974;290(26):1450-2. [Medline].

  35. Carlson DE, Platt LD, Medearis AL, Horenstein J. Prognostic indicators of the resolution of nonimmune hydrops fetalis and survival of the fetus. Am J Obstet Gynecol. Dec 1990;163(6 Pt 1):1785-7. [Medline].

  36. Cowan RH, Waldo AL, Harris HB, et al. Neonatal paroxysmal supraventricular tachycardia with hydrops. Pediatrics. Mar 1975;55(3):428-30. [Medline].

  37. Daniel SJ, Cassady G. Non-immunologic hydrops fetalis associated with a large hemangioendothelioma. Pediatrics. Nov 1968;42(5):828-33. [Medline].

  38. De Groot CJ, Oepkes D, Egberts J, Kanhai HH. Evidence of endothelium involvement in the pathophysiology of hydrops fetalis?. Early Hum Dev. Mar 2000;57(3):205-9. [Medline].

  39. Dieck D, Schild RL, Hansmann M, Eis-Hubinger AM. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn. Dec 1999;19(12):1119-23. [Medline].

  40. Driscoll SG. Hydrops fetalis. N Engl J Med. Dec 22 1966;275(25):1432-4. [Medline].

  41. Dumez Y, Mandelbrot L, Radunovic N, et al. Prenatal management of congenital cystic adenomatoid malformation of the lung. J Pediatr Surg. Jan 1993;28(1):36-41. [Medline].

  42. Faber JJ, Anderson DF. Angiotensin mediated interaction of fetal kidney and placenta in the control of fetal arterial pressure and its role in hydrops fetalis. Placenta. May 1997;18(4):313-26. [Medline].

  43. Gembruch U, Knopfle G, Chatterjee M, et al. First-trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography. Obstet Gynecol. Mar 1990;75(3 Pt 2):496-8. [Medline].

  44. Gest AL, Bair DK, Vander Straten MC. The effect of outflow pressure upon thoracic duct lymph flow rate in fetal sheep. Pediatr Res. Nov 1992;32(5):585-8. [Medline].

  45. Gest AL, Hansen TN, Moise AA, Hartley CJ. Atrial tachycardia causes hydrops in fetal lambs. Am J Physiol. Apr 1990;258(4 Pt 2):H1159-63. [Medline].

  46. Gest AL, Martin CG, Moise AA, Hansen TN. Reversal of venous blood flow with atrial tachycardia and hydrops in fetal sheep. Pediatr Res. Sep 1990;28(3):223-6. [Medline].

  47. Giacoia GP. Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv. Jun 1997;52(6):372-80. [Medline].

  48. Gudmundsson S, Huhta JC, Wood DC, et al. Venous Doppler ultrasonography in the fetus with nonimmune hydrops. Am J Obstet Gynecol. Jan 1991;164(1 Pt 1):33-7. [Medline].

  49. Haak MC, Oosterhof H, Mouw RJ. Pathophysiology and treatment of fetal anemia due to placental chorioangioma. Ultrasound Obstet Gynecol. Jul 1999;14(1):68-70. [Medline].

  50. Hagay Z, Reece A, Roberts A, Hobbins JC. Isolated fetal pleural effusion: a prenatal management dilemma. Obstet Gynecol. Jan 1993;81(1):147-52. [Medline].

  51. Haverkamp F, Noeker M, Gerresheim G, Fahnenstich H. Good prognosis for psychomotor development in survivors with nonimmune hydrops fetalis. Br J Obstet Gynaecol. Feb 2000;107(2):282-4. [Medline].

  52. Hirata GI, Masaki DI, O'Toole M, Medearis AL, Platt LD. Color flow mapping and Doppler velocimetry in the diagnosis and management of a placental chorioangioma associated with nonimmune fetal hydrops. Obstet Gynecol. May 1993;81(5 ( Pt 2)):850-2. [Medline].

  53. Khouzami AN, Kickler TS, Callan NA, et al. Devastating sequelae of alloimmune thrombocytopenia: an entity that deserves more attention. J Matern Fetal Med. May-Jun 1996;5(3):137-41. [Medline].

  54. Kirshon B, Moise KJ Jr, Mari G, et al. In utero resolution of hydrops fetalis following the death of one twin in twin-twin transfusion. Am J Perinatol. Apr 1990;7(2):107-9. [Medline].

  55. Knilans TK. Cardiac abnormalities associated with hydrops fetalis. Semin Perinatol. Dec 1995;19(6):483-92. [Medline].

  56. Liddle AD, Anderson DR, Mishra PK. Intrapericardial teratoma presenting in fetal life: intrauterine diagnosis and neonatal management. Congenit Heart Dis. Nov-Dec 2008;3(6):449-51. [Medline].

  57. Mahone PR, Sherer DM, Abramowicz JS, Woods JR Jr. Twin-twin transfusion syndrome: rapid development of severe hydrops of the donor following selective feticide of the hydropic recipient. Am J Obstet Gynecol. Jul 1993;169(1):166-8. [Medline].

  58. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. Feb 1998;105(2):174-8. [Medline].

  59. Moise AA, Gest AL, Weickmann PH, McMicken HW. Reduction in plasma protein does not affect body water content in fetal sheep. Pediatr Res. Jun 1991;29(6):623-6. [Medline].

  60. Moise KJ Jr, Carpenter RJ Jr, Hesketh DE. Do abnormal Starling forces cause fetal hydrops in red blood cell alloimmunization?. Am J Obstet Gynecol. Oct 1992;167(4 Pt 1):907-12. [Medline].

  61. Moya FR, Grannum PA, Riddick L, et al. Atrial natriuretic factor in hydrops fetalis caused by Rh isoimmunisation. Arch Dis Child. Jul 1990;65(7 Spec No):683-6. [Medline].

  62. Moya FR, Grannum PA, Widness JA, et al. Erythropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis. Obstet Gynecol. Sep 1993;82(3):353-8. [Medline].

  63. Muller-Hansen I, Hackeloer BJ, Kattner E. [Pre- and postnatal diagnosis and treatment of hydrops fetalis--an interdisciplinary problem]. Z Geburtshilfe Neonatol. Jan-Feb 1998;202(1):2-9. [Medline].

  64. Murphy JJ, Blair GK, Fraser GC. Coagulopathy associated with large sacrococcygeal teratomas. J Pediatr Surg. Oct 1992;27(10):1308-10. [Medline].

  65. Nimrod C, Davies D, Harder J. Ultrasound evaluation of tachycardia-induced hydrops in the fetal lamb. Am J Obstet Gynecol. Sep 1987;157(3):655-9. [Medline].

  66. Nimrod C, Keane P, Harder J, et al. Atrial natriuretic peptide production in association with nonimmune fetal hydrops. Am J Obstet Gynecol. Sep 1988;159(3):625-8. [Medline].

  67. O-Prasertsawat P, Suthutvoravut S, Chaturachinda K. Hydrops fetalis due to Bart hemoglobinopathy at Ramathibodi Hospital (1978-1987): a 10-year review. J Med Assoc Thai. Feb 1990;73 Suppl 1:65-8. [Medline].

  68. Owen J, Colvin EV, Davis RO. Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil. Am J Obstet Gynecol. May 1988;158(5):1169-70. [Medline].

  69. Paladini D, Chita SK, Allan LD. Prenatal measurement of cardiothoracic ratio in evaluation of heart disease. Arch Dis Child. Jan 1990;65(1 Spec No):20-3. [Medline].

  70. Phibbs RH, Johnson P, Tooley WH. Cardiorespiratory status of erythroblastotic newborn infants. II. Blood volume, hematocrit, and serum albumin concentration in relation to hydrops fetalis. Pediatrics. Jan 1974;53(1):13-23. [Medline].

  71. Potter EL. Universal edema of the fetus unassociated with erythroblastosis. Am J Obstet Gynecol. 1943;46:130-134.

  72. Revillon Y, Jan D, Plattner V, et al. Congenital cystic adenomatoid malformation of the lung: prenatal management and prognosis. J Pediatr Surg. Aug 1993;28(8):1009-11. [Medline].

  73. Rice HE, Estes JM, Hedrick MH, et al. Congenital cystic adenomatoid malformation: a sheep model of fetal hydrops. J Pediatr Surg. May 1994;29(5):692-6. [Medline].

  74. Rodis JF, Borgida AF, Wilson M, et al. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol. Oct 1998;179(4):985-8. [Medline].

  75. Ross BA. Congenital complete atrioventricular block. Pediatr Clin North Am. Feb 1990;37(1):69-78. [Medline].

  76. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum. Nov 1999;42(11):2335-45. [Medline].

  77. Sharma RS, Yu V, Walters WA. Haemoglobin Bart's hydrops fetalis syndrome in an infant of Greek origin and prenatal diagnosis of alpha-thalassaemia. Med J Aust. Oct 20 1979;2(8):404, 433-4. [Medline].

  78. Shimokawa H, Sumioki H, Miyamoto S, et al. Is human atrial natriuretic peptide in fetal blood useful as a parameter to detect the decompensated state of the fetal heart?. J Perinat Med. 1988;16(5-6):485-6. [Medline].

  79. Shiraishi S, Kinukawa N, Nakano H, Sueishi K. Immunohistochemical distribution of vascular endothelial growth factor in the human placenta associated with hydrops fetalis. Pediatr Pathol Lab Med. Jan-Feb 1997;17(1):65-81. [Medline].

  80. Silberbach M, Anderson DF, Reller MD. Effect of atrial natriuretic peptide on vascular permeation in the ovine fetus. Pediatr Res. May 1994;35(5):555-9. [Medline].

  81. Silberbach M, Woods LL, Hohimer AR, et al. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor. Pediatr Res. Nov 1995;38(5):722-8. [Medline].

  82. Silverman NH, Schmidt KG. Ventricular volume overload in the human fetus: observations from fetal echocardiography. J Am Soc Echocardiogr. Jan-Feb 1990;3(1):20-9. [Medline].

  83. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. Jun 1998;79(6):576-81. [Medline]. [Full Text].

  84. Strasburger JF, Huhta JC, Carpenter RJ Jr, et al. Doppler echocardiography in the diagnosis and management of persistent fetal arrhythmias. J Am Coll Cardiol. Jun 1986;7(6):1386-91. [Medline].

  85. Sun CC, Panny S, Combs J, Gutberlett R. Hydrops fetalis associated with Gaucher disease. Pathol Res Pract. Sep 1984;179(1):101-4. [Medline].

  86. Tannirandorn Y, Fisk NM, Shah V, et al. Plasma renin activity in fetal disease. J Perinat Med. 1990;18(3):229-31. [Medline].

  87. Thorpe-Beeston JG, Nicolaides KH. Cystic adenomatoid malformation of the lung: prenatal diagnosis and outcome. Prenat Diagn. Aug 1994;14(8):677-88. [Medline].

  88. Tongsong T, Wanapirak C, Piyamongkol W, Sudasana J. Prenatal sonographic features of sacrococcygeal teratoma. Int J Gynaecol Obstet. Nov 1999;67(2):95-101. [Medline].

  89. Ulm B, Svolba G, Ulm MR, et al. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion. Feb 1999;39(2):169-73. [Medline].

  90. van der Straten MC, Gest AL. Hemolytic anemia without an increased central venous pressure does not cause hydrops in fetal sheep (Abstract). Clin Res. 1993;41:771A.

  91. van Engelen AD, Weijtens O, Brenner JI, et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol. Nov 1 1994;24(5):1371-5. [Medline].

  92. Venkat-Raman N, Sebire NJ, Murphy KW. Recurrent fetal hydrops due to mucopolysaccharidoses type VII. Fetal Diagn Ther. 2006;21(3):250-4. [Medline].

  93. Ville Y, Proudler A, Kuhn P, Nicolaides KH. Aldosterone concentration in normal, growth-retarded, anemic, and hydropic fetuses. Obstet Gynecol. Oct 1994;84(4):511-4. [Medline].

  94. Watson J, Campbell S. Antenatal evaluation and management in nonimmune hydrops fetalis. Obstet Gynecol. Apr 1986;67(4):589-93. [Medline].

  95. Weiner CP, Pelzer GD, Heilskov J, et al. The effect of intravascular transfusion on umbilical venous pressure in anemic fetuses with and without hydrops. Am J Obstet Gynecol. Dec 1989;161(6 Pt 1):1498-501. [Medline].

  96. Weiner CP, Robillard JE. Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease. Am J Obstet Gynecol. Dec 1988;159(6):1353-60. [Medline].

  97. Whitecar PW, Moise KJ Jr. Sonographic methods to detect fetal anemia in red blood cell alloimmunization. Obstet Gynecol Surv. Apr 2000;55(4):240-50. [Medline].

  98. Williams IA, Kleinman CS. Is hydrops fetalis a manifestation of fetal pulmonary edema caused by impaired lymphatic drainage?. Ultrasound Obstet Gynecol. Jan 2008;31(1):96-9. [Medline].

  99. Wolf RB, Moore TR. Amniotic fluid and nonimmune hydrops fetalis. In: Fanaroff and Martin's Neonatal-Perinatal Medicine. 8th ed. 2006:409-28.

  100. Yaegashi N, Niinuma T, Chisaka H, et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect. Jul 1998;37(1):28-35. [Medline].

  101. Yamada A, Kasugai M, Ohno Y, et al. Antenatal diagnosis of twin-twin transfusion syndrome by Doppler ultrasound. Obstet Gynecol. Dec 1991;78(6):1058-61. [Medline].

  102. Yamada H, Kato EH, Furuta I, et al. Hematopoietic cytokine levels and in vitro colony formation assay in fetal anemia. Semin Thromb Hemost. 1998;24(5):485-90. [Medline].

  103. Zankl A, Osterheld MC, Vial Y, Beurret N, et al. Right-sided diaphragmatic eventration: a rare cause of non-immune hydrops fetalis. Neonatology. 2007;92(1):14-8. [Medline].

 
Previous
Next
 
Chest radiograph revealing pleural effusion with bilateral chest tubes and severe edema.
Chest and abdomen radiograph revealing severe edema and ascites.
Chest and abdomen radiograph revealing severe edema, pleural effusion, and bilateral chest tubes. Umbilical artery catheter, umbilical vein catheter, and endotracheal tube in place.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.